TEC Finds iFOBT Test Evidence Lacking In Contrast To Medicare Decision
This article was originally published in The Gray Sheet
A 1BlueCross BlueShield Association TEC assessment finding insufficient evidence on the use of immunochemical fecal occult blood tests contradicts a recent positive Medicare national coverage decision
You may also be interested in...
The combination of guaiac and immunochemical fecal occult blood testing can reduce the need for colonoscopies by 30%, according to a Lancet study published Jan. 5
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.